Federal Joint Committee (Germany)

Last updated
Federal Joint Committee
Gemeinsamer Bundesausschuss
(G-BA)
AbbreviationG-BA
FormationJanuary 1, 2004;20 years ago (2004-01-01)
Headquarters Berlin, Germany
Region
Germany
Official language
German
Chair
Josef Hecken
Website g-ba.de/english/

The Federal Joint Committee (German : Gemeinsamer Bundesausschuss (G-BA)) refers to a group of German public health agencies that were merged in 2004, under an independent chairman. [1] It is authorized to make binding regulations growing out of health reform bills passed by lawmakers, along with routine decisions regarding healthcare in Germany. [1]

Contents

Although the committee is not a subordinate agency and is independent of the Ministry of Health, government officials are responsible for exercising legal supervision over the committee's decisions and guidelines. As a supreme decision-making body, the Committee exerts a direct influence on the healthcare provisions for millions of people. [2]

History

The Federal Joint Committee (G-BA) was formed in 2004 by the merger of the following organizations

These organizations had been created several decades ago[ when? ] to ensure supervision of the professional relationship between doctors and health insurers. Their roots can be partially traced back to the Weimar Republic in the late-1910s and 1920s. [3] In 2004, they were renamed and merged into the Federal Joint Committee (G-BA) as follows:

As a supreme decision-making body, the Joint Committee exerts a direct influence on the healthcare provisions for millions of people. [2]

Decision-making process

In the early stages of the Committee's decision-making process, assessment reports of diagnostic or therapeutic interventions are prepared by the Institute for Quality and Efficiency in Health Care on behalf of the committee. [5] All resolutions and guidelines passed by the Federal Joint Committee are subsequently audited by the Ministry of Health. [4]

The directives issued by the committee are legally binding for publicly insured persons as well as for the providers and payers of health care. In total, healthcare provisions for 70 million people, excluding those who are privately insured, are determined by the committee. [2]

Notable guidelines

Following the German acupuncture trials from 2002 to 2006, the Committee decided to include acupuncture into the catalogue of services covered by statutory health insurance organizations for the treatment of low back pain and knee pain. [6]

On June 17, 2010, the Committee removed the usage of glinides from general prescription guidelines for the reduction of human glucose levels. It justified its decision by referring to the conclusion of the Institute for Quality and Efficiency in Health Care that proof of efficacy was lacking. [7]

In 2013, the Committee issued a preliminary decision ruling that a fixed dose combination of Stribild does not offer a benefit over Atripla for HIV treatment. [8]

See also

Related Research Articles

<i>Canada Health Act</i> Canadian federal law for health care funding

The Canada Health Act, adopted in 1984, is the federal legislation in Canada for publicly-funded health insurance, commonly called "medicare", and sets out the primary objective of Canadian healthcare policy.

Health insurance or medical insurance is a type of insurance that covers the whole or a part of the risk of a person incurring medical expenses. As with other types of insurance, risk is shared among many individuals. By estimating the overall risk of health risk and health system expenses over the risk pool, an insurer can develop a routine finance structure, such as a monthly premium or payroll tax, to provide the money to pay for the health care benefits specified in the insurance agreement. The benefit is administered by a central organization, such as a government agency, private business, or not-for-profit entity.

Insurance fraud refers to any intentional act committed to deceive or mislead an insurance company during the application or claims process, or the wrongful denial of a legitimate claim by an insurance company. It occurs when a claimant knowingly attempts to obtain a benefit or advantage they are not entitled to receive, or when an insurer knowingly denies a benefit or advantage that is due to the insured. According to the United States Federal Bureau of Investigation, the most common schemes include premium diversion, fee churning, asset diversion, and workers compensation fraud. False insurance claims are insurance claims filed with the fraudulent intention towards an insurance provider.

<span class="mw-page-title-main">Healthcare in Switzerland</span>

Switzerland has universal health care, regulated by the Swiss Federal Law on Health Insurance. There are no free state-provided health services, but private health insurance is compulsory for all persons residing in Switzerland.

<span class="mw-page-title-main">Massachusetts health care reform</span> 2006 healthcare reform law in Massachusetts

The Massachusetts health care reform, commonly referred to as Romneycare, was a healthcare reform law passed in 2006 and signed into law by Governor Mitt Romney with the aim of providing health insurance to nearly all of the residents of the Commonwealth of Massachusetts.

Utilization management (UM) or utilization review is the use of managed care techniques such as prior authorization that allow payers, particularly health insurance companies, to manage the cost of health care benefits by assessing its medical appropriateness before it is provided, by using evidence-based criteria or guidelines.

<span class="mw-page-title-main">Federal Ministry of Health (Germany)</span> Cabinet-level ministry of Germany

The Federal Ministry of Health, abbreviated BMG, is a cabinet-level ministry of the Federal Republic of Germany. It is the highest German federal government department responsible for health. The ministry is officially located in Bonn and with a second office, which houses the ministry's management, located in Berlin.

Insurance law is the practice of law surrounding insurance, including insurance policies and claims. It can be broadly broken into three categories - regulation of the business of insurance; regulation of the content of insurance policies, especially with regard to consumer policies; and regulation of claim handling wise.

<span class="mw-page-title-main">Brivaracetam</span> Medication used to treat seizures

Brivaracetam, sold under the brand name Briviact among others, is a chemical analog of levetiracetam, a racetam derivative with anticonvulsant (antiepileptic) properties. It has been approved since 2016. It is marketed by the pharmaceutical company UCB. It is used to treat partial-onset seizures with or without secondary generalisation, in combination with other antiepileptic drugs.

<span class="mw-page-title-main">Confederation of German Employers' Associations</span> Organization of German employers associations

The Confederation of German Employers' Associations or BDA is the umbrella organization for German employers' associations. It represents interest groups in the areas of industry, the tertiary sector, banking, commerce, transport, trade and agriculture.

Regulation of acupuncture is done by governmental bodies to ensure safe practice.

<span class="mw-page-title-main">German Agency for Quality in Medicine</span>

The German Agency for Quality in Medicine (AEZQ), established in 1995 and located in Berlin, co-ordinates healthcare quality programmes with special focus on evidence-based medicine, medical guidelines, patient empowerment, patient safety programs, and quality management.

Zeitschrift für Evidenz, Fortbildung und Qualität im Gesundheitswesen is a bilingual German and English language peer-reviewed medical journal published by Elsevier Germany. It was established in 1904 as the Zeitschrift für ärztliche Fortbildung by Ernst von Bergmann. ZEFQ is the organ of various organisations working in the fields of evidence-based medicine, patient empowerment, patient safety, and quality management in healthcare:. Among these are:

<span class="mw-page-title-main">Healthcare in Germany</span>

Germany has a universal multi-payer health care system paid for by a combination of statutory health insurance and private health insurance.

The Institute for Quality and Efficiency in Healthcare (IQWiG) is a German agency responsible for assessing the quality and efficiency of medical treatments, including drugs, non-drug interventions, diagnostic and screening methods, and treatment and disease management. IQWiG also supplies health information to patients and the general public.

<span class="mw-page-title-main">Healthcare in Austria</span>

The nation of Austria has a two-tier health care system in which virtually all individuals receive publicly funded care, but they also have the option to purchase supplementary private health insurance. Care involving private insurance plans can include more flexible visiting hours and private rooms and doctors. Some individuals choose to completely pay for their care privately.

<span class="mw-page-title-main">National Association of Statutory Health Insurance Physicians</span>

The National Association of Statutory Health Insurance Physicians (NASHIP), based in Berlin, is the co-ordinating body of all 17 State Associations of Statutory Health Insurance Physicians in Germany. As of 2018, it represented about 175,000 office-based physicians' and psychotherapists in Germany. NASHIP is co-owner of the medical journal Deutsches Ärzteblatt and of the German Agency for Quality in Medicine, a member of the Guidelines International Network - together with the German Medical Association.

<span class="mw-page-title-main">German acupuncture trials</span>

The German acupuncture trials were a series of nationwide acupuncture trials set up in 2001 and published in 2006 on behalf of several German statutory health insurance companies because of a dispute as to the usefulness of acupuncture. They consisted of one observational study on acupuncture side effects, and four randomized controlled trials (RCTs) investigating acupuncture treatment for low back pain, knee osteoarthritis, migraine prophylaxis, and tension-type headache. The trials are considered to be one of the largest clinical studies in the field of acupuncture.

Social security in Germany is codified on the Sozialgesetzbuch (SGB), or the "Social Code", contains 12 main parts, including the following,

The Otto-Selz-Institute (OSI) is an interdisciplinary research institute at the University of Mannheim. It combines research, teaching and therapy.

References

  1. 1 2 E. REINHARDT, UWE (2009-07-24). "A German Import That Could Help U.S. Health Reform". The New York Times . Retrieved 25 May 2013. Germany's joint committee was established in 2004 and authorized to make binding regulations growing out of health reform bills passed by lawmakers, along with routine coverage decisions. The ministry of health reserves the right to review the regulations for final approval or modification. The joint committee has a permanent staff and an independent chairman.
  2. 1 2 3 Fricke, Frank-Ulrich; Dauben, Hans Peter (June 2009). "Health Technology Assessment: A Perspective from Germany". Value in Health. 12: S20–S27. doi: 10.1111/j.1524-4733.2009.00555.x . PMID   19523181. The G-BA is the supreme decision-making body of the so-called self-governing system in Germany. Physicians, dentists, hospitals, sickness funds, and patients are represented in the G-BA. The G-BA issues directives and, thus, determines the benefit package of the SHI covering about 70 million people. Finally, the G-BA is responsible for reimbursement decisions.
  3. 1 2 3 4 5 Kälble, Bernhard Borgetto ; Karl (2007). Medizinsoziologie : sozialer Wandel, Krankheit, Gesundheit und das Gesundheitssystem (in German). Weinheim: Juventa-Verl. p. 184. ISBN   9783779914846.{{cite book}}: CS1 maint: multiple names: authors list (link)
  4. 1 2 3 4 "The Federal Joint Committee: Who we are and what we do". Gemeinsamer Bundesausschuss. Retrieved 25 May 2013.
  5. Wieseler, B.; McGauran, N.; Kaiser, T. (12 October 2010). "Finding studies on reboxetine: a tale of hide and seek". BMJ . 341: c4942. doi:10.1136/bmj.c4942. PMID   20940211. Produces health technology assessments on diagnostic or therapeutic interventions and health economic evaluations for the Federal Joint Committee (G-BA)—the statutory health insurance system's main decision making body
  6. Karin Hertzer (August 12, 2009). "Akupunktur ist wirksam". Focus (German magazine) (in German). Der Gemeinsame Bundesausschuss der Ärzte und Krankenkassen entschied dann im April 2006, die Akupunktur als Kassenleistung gegen Rücken- und Knieschmerzen anzuerkennen.
  7. Kreis, J; Busse, R (January 2012). "From evidence assessments to coverage decisions?: the case example of glinides in Germany". Health Policy (Amsterdam, Netherlands). 104 (1): 27–31. doi:10.1016/j.healthpol.2011.11.006. PMID   22136812.
  8. Ed Silverma (2013-09-18). "Will German Regulators Dampen Gilead Hopes For Its Stribild AIDS Drug?". Forbes . Retrieved 20 November 2013.